Article info
Electronic letters
Modifier controls severity of a novel dominant low-frequency MyosinVIIA (MYO7A) auditory mutation
- Correspondence to: Dr V Street Box 357923, V.M. Bloedel Hearing Research Center, Otolaryngology – HNS Department, University of Washington, Seattle, WA 98195; vastreetu.washington.edu
Citation
Modifier controls severity of a novel dominant low-frequency MyosinVIIA (MYO7A) auditory mutation
Publication history
- First published April 30, 2004.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Medical Genetics